Case study on the effect of T-AYU-HM Premium along with modern medicines in Covid-19 patient with comorbidities
Atul Desai
, Kavita Desai , Hemshree Desai , Rutvij Desai , Chirag Desai
Covid-19, T-AYU-HM Premium, D-Dimer, CRP, ESR, Comorbidities
Patients with existing comorbidities or those who are elderly have a poor prognosis. Generally, existing comorbidities in covid-19 patients exhibit increased chances of mortality and require a longer treatment period. This pandemic has now reached a stage where there is a dire need to incorporate an integrated treatment approach for combating such conditions. Here, we present a case study on the clinical outcome of the integrated treatment approach in Covid-19 patients with pre-existing comorbidities. The patient is a known case of type 2 diabetes mellitus, hypertension, hypothyroidism, and arthritis. He was on his medication at the time. On infection with coronavirus, he was advised of the standard treatment plan and strict home quarantine. He presented to the covid-19 healthcare center with complaints of weakness, breathlessness on exertion, cough, loss of appetite. On examination, he had a 93% oxygen saturation and had hematological findings; CRP 33.3(mg/dL), ESR 112(mm/hour), D-dimer 2470(ng/mL), LDH 2485 (Units/L), RBS 596 mg/d. He provided his informed consent to proceed with the integrated treatment approach. The integrated treatment approach along modern medicine includes T-AYU-HM Premium 600mg and Acupen 600mg thrice a day. The treatment plan has resulted in remarkable improvement in the clinical profile and the inflammatory markers of patients. It has managed the blood glucose level in the patient and preventing unwanted complications associated with it. This case study provides information about the importance of an integrated treatment approach in the treatment of Covid-19 with existing co-morbidities.
"Case study on the effect of T-AYU-HM Premium along with modern medicines in Covid-19 patient with comorbidities", IJSDR - International Journal of Scientific Development and Research (www.IJSDR.org), ISSN:2455-2631, Vol.6, Issue 8, page no.38 - 41, August-2021, Available :https://ijsdr.org/papers/IJSDR2108007.pdf
Volume 6
Issue 8,
August-2021
Pages : 38 - 41
Paper Reg. ID: IJSDR_193582
Published Paper Id: IJSDR2108007
Downloads: 000347309
Research Area: Engineering
Country: -, -, -
ISSN: 2455-2631 | IMPACT FACTOR: 9.15 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 9.15 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJSDR(IJ Publication) Janvi Wave